IL113167A - A substance that gives shape to a sustained-release pharmaceutical preparation containing tropopolysaccharide rubber, its nuclei and methods of preparation - Google Patents

A substance that gives shape to a sustained-release pharmaceutical preparation containing tropopolysaccharide rubber, its nuclei and methods of preparation

Info

Publication number
IL113167A
IL113167A IL11316795A IL11316795A IL113167A IL 113167 A IL113167 A IL 113167A IL 11316795 A IL11316795 A IL 11316795A IL 11316795 A IL11316795 A IL 11316795A IL 113167 A IL113167 A IL 113167A
Authority
IL
Israel
Prior art keywords
sustained release
excipient
linking agent
gum
release excipient
Prior art date
Application number
IL11316795A
Other languages
English (en)
Hebrew (he)
Other versions
IL113167A0 (en
Original Assignee
Mendell Co Inc Edward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Co Inc Edward filed Critical Mendell Co Inc Edward
Publication of IL113167A0 publication Critical patent/IL113167A0/xx
Publication of IL113167A publication Critical patent/IL113167A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Push-Button Switches (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Superstructure Of Vehicle (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
IL11316795A 1994-04-25 1995-03-28 A substance that gives shape to a sustained-release pharmaceutical preparation containing tropopolysaccharide rubber, its nuclei and methods of preparation IL113167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25

Publications (2)

Publication Number Publication Date
IL113167A0 IL113167A0 (en) 1995-06-29
IL113167A true IL113167A (en) 2001-01-28

Family

ID=22873888

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11316795A IL113167A (en) 1994-04-25 1995-03-28 A substance that gives shape to a sustained-release pharmaceutical preparation containing tropopolysaccharide rubber, its nuclei and methods of preparation

Country Status (18)

Country Link
EP (2) EP1145712B1 (fr)
JP (1) JP3279318B2 (fr)
KR (1) KR100232020B1 (fr)
CN (1) CN1131023C (fr)
AT (2) ATE308318T1 (fr)
AU (1) AU705378B2 (fr)
CA (1) CA2164513C (fr)
DE (2) DE69534575T2 (fr)
DK (1) DK0706377T3 (fr)
ES (2) ES2164764T3 (fr)
FI (1) FI119353B (fr)
HK (1) HK1040487B (fr)
HU (1) HU219818B (fr)
IL (1) IL113167A (fr)
MX (1) MX9600022A (fr)
PT (1) PT706377E (fr)
TW (1) TW357085B (fr)
WO (1) WO1995028916A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096834A (en) * 1997-04-04 2000-08-01 Monsanto Company Hydrolyzable delivery system using crosslinked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
AU6783498A (en) 1997-04-04 1998-10-30 Monsanto Company Ph-selective delivery system using cross-linked polymeric resins as vehicles
WO2003004031A1 (fr) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Administration parenterale de 6-hydroxy-oxymorphone destinee a etre utilisee en tant qu'analgesique
EP1429730A4 (fr) * 2001-09-26 2010-06-16 Penwest Pharmaceuticals Compan Formulations d'opioides presentant un potentiel reduit pour des utilisations abusives
MXPA04009701A (es) * 2002-04-05 2005-05-27 Penwest Pharmaceuticals Co Formulaciones de metoprolol de liberacion sostenida.
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
JPH08512061A (ja) 1996-12-17
FI119353B (fi) 2008-10-31
KR100232020B1 (ko) 1999-12-01
ATE209906T1 (de) 2001-12-15
EP0706377A1 (fr) 1996-04-17
HU219818B (hu) 2001-08-28
AU2198295A (en) 1995-11-16
ES2246961T3 (es) 2006-03-01
EP1145712B1 (fr) 2005-11-02
AU705378B2 (en) 1999-05-20
DE69534575T2 (de) 2006-07-13
HUT73636A (en) 1996-08-28
TW357085B (en) 1999-05-01
IL113167A0 (en) 1995-06-29
CA2164513C (fr) 1999-09-21
ES2164764T3 (es) 2002-03-01
FI956209A0 (fi) 1995-12-22
KR960703016A (ko) 1996-06-19
JP3279318B2 (ja) 2002-04-30
DK0706377T3 (da) 2002-04-02
DE69524358T2 (de) 2002-06-13
EP0706377B1 (fr) 2001-12-05
MX9600022A (es) 1998-06-30
DE69534575D1 (de) 2005-12-08
EP1145712A1 (fr) 2001-10-17
HK1040487B (zh) 2006-05-12
CN1131023C (zh) 2003-12-17
CN1127469A (zh) 1996-07-24
PT706377E (pt) 2002-05-31
HK1040487A1 (en) 2002-06-14
ATE308318T1 (de) 2005-11-15
FI956209A (fi) 1995-12-22
HU9503456D0 (en) 1996-02-28
EP0706377A4 (fr) 1996-11-06
DE69524358D1 (de) 2002-01-17
WO1995028916A1 (fr) 1995-11-02
CA2164513A1 (fr) 1995-11-02

Similar Documents

Publication Publication Date Title
US6039980A (en) Sustained release excipient
US5478574A (en) Agglomerated hydrophilic complexes with multi-phasic release characteristics
EP0804166B1 (fr) Formulation a liberation controlee (albuterol)
EP0360562B1 (fr) Excipient pour compression directe à libération retardée
AU684944B2 (en) Once-a-day metoprolol oral dosage form
CA2231195C (fr) Matrice a liberation prolongee pour medicaments insolubles en doses elevees
WO1997016172A9 (fr) Formulation a liberation controlee (albuterol)
AU2403392A (en) Controlled release verapamil tablet
EP0706377B1 (fr) Excipient a liberation prolongee
MXPA96000024A (en) Form of oral dosing of metoprolol one time

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired